115 related articles for article (PubMed ID: 33427019)
1. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
Descoeur J; Dupuy AM; Bargnoux AS; Cristol JP; Mathieu O
J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
[TBL] [Abstract][Full Text] [Related]
2. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
Günther V; Mueller D; von Eckardstein A; Saleh L
Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
5. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
6. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
[TBL] [Abstract][Full Text] [Related]
7. Determination of methotrexate and 7-hydroxymethotrexate by liquid chromatography for routine monitoring of plasma levels.
Cociglio M; Hillaire-Buys D; Alric C
J Chromatogr B Biomed Appl; 1995 Dec; 674(1):101-10. PubMed ID: 8749257
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical assays for measuring high-dose methotrexate in plasma.
Albertioni F; Rask C; Eksborg S; Poulsen JH; Pettersson B; Beck O; Schroeder H; Peterson C
Clin Chem; 1996 Jan; 42(1):39-44. PubMed ID: 8565230
[TBL] [Abstract][Full Text] [Related]
9. Interference of 7-hydroxymethotrexate with the determination of methotrexate in plasma samples from children with acute lymphoblastic leukemia employing routine clinical assays.
Fotoohi K; Skärby T; Söderhäll S; Peterson C; Albertioni F
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):139-44. PubMed ID: 15686977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new high-performance liquid chromatography method with fluorescence polarization immunoassay for analysis of methotrexate.
Najjar TA; Matar KM; Alfawaz IM
Ther Drug Monit; 1992 Apr; 14(2):142-6. PubMed ID: 1585400
[TBL] [Abstract][Full Text] [Related]
11. Measurement of methotrexate in human cerebrospinal fluid using a chemiluminescence immunoassay intended for serum and plasma matrices.
Yoshikawa N; Yamada A; Yokota T; Moritake H; Hirabara Y; Ikeda R
J Clin Lab Anal; 2021 Mar; 35(3):e23661. PubMed ID: 33225528
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid.
Castoldi S; Cozzi V; Baldelli S; Fucile S; Clementi E; Cattaneo D
Ther Drug Monit; 2018 Feb; 40(1):140-143. PubMed ID: 29324625
[TBL] [Abstract][Full Text] [Related]
13. UPLC-MS/MS Analysis of Methotrexate in Human Plasma and Comparison with the Fluorescence Polarization Immunoassay.
Mei S; Zhu L; Li X; Wang J; Jiang X; Chen H; Huo J; Yang L; Lin S; Zhao Z
Anal Sci; 2017; 33(6):665-670. PubMed ID: 28603183
[TBL] [Abstract][Full Text] [Related]
14. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
[TBL] [Abstract][Full Text] [Related]
15. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate measurements in plasma: comparison of enzyme multiplied immunoassay technique, TDx fluorescence polarization immunoassay, and high pressure liquid chromatography.
Slørdal L; Prytz PS; Pettersen I; Aarbakke J
Ther Drug Monit; 1986; 8(3):368-72. PubMed ID: 3529519
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of levetiracetam: comparison of a novel immunoassay with an HPLC method.
Bianchi V; Arfini C; Vidali M
Ther Drug Monit; 2014 Oct; 36(5):681-5. PubMed ID: 24577125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole.
Peña-Lorenzo D; Rebollo N; Sánchez-Hernández JG; Zarzuelo-Castañeda A
Ann Clin Biochem; 2021 Nov; 58(6):657-660. PubMed ID: 34482744
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of time to clearance of high-dose methotrexate using the ARK immunoassay in pediatric hematology/oncology patients: A single-center experience.
Kowalski KE; Higgins TA
Pediatr Blood Cancer; 2021 Mar; 68(3):e28788. PubMed ID: 33164288
[TBL] [Abstract][Full Text] [Related]
20. A U-HPLC-ESI-MS/MS-based stable isotope dilution method for the detection and quantitation of methotrexate in plasma.
den Boer E; Heil SG; van Zelst BD; Meesters RJ; Koch BC; Te Winkel ML; van den Heuvel-Eibrink MM; Luider TM; de Jonge R
Ther Drug Monit; 2012 Aug; 34(4):432-9. PubMed ID: 22689188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
